CFTR modulator program (Eloxx Pharmaceuticals)

N/A

Report date: 2025/03/18 18:08:43
NME

Base Information

Drug NameCFTR modulator program (Eloxx Pharmaceuticals)
Drug Alias Nameribosome modulating agents (Eloxx Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEloxx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEloxx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A